The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

A groundbreaking brain imaging study shows why the gold-standard Parkinson’s drug doesn’t work for everyone—and how doctors ...

In a breakthrough study, scientists found that silencing a single overactive enzyme in the brain reversed early damage caused ...

When 64-year-old MBK Nair first noticed a subtle tremor in his right hand in 2020, he brushed it off as fatigue or muscle ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

Despite a significant improvement in symptoms, around 20% of patients discontinued treatment due to adverse events.

Scientists find volatile compounds in ear wax may help detect Parkinson's disease earlier than traditional methods, offering ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

Four compounds in ear canal secretions differ between those with and without Parkinson’s disease, suggesting they may be ...